Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Oncol ; 49(4): 1541-1552, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27634112

ABSTRACT

Field effect or field cancerization denotes the presence of molecular aberrations in structurally intact cells residing in histologically normal tissues adjacent to solid tumors. Currently, the etiology of prostate field­effect formation is unknown and there is a prominent lack of knowledge of the underlying cellular and molecular pathways. We have previously identified an upregulated expression of several protein factors representative of prostate field effect, i.e., early growth response-1 (EGR­1), platelet-derived growth factor­A (PDGF­A), macrophage inhibitory cytokine­1 (MIC­1), and fatty acid synthase (FASN) in tissues at a distance of 1 cm from the visible margin of intracapsule prostate adenocarcinomas. We have hypothesized that the transcription factor EGR­1 could be a key regulator of prostate field­effect formation by controlling the expression of PDGF­A, MIC­1, and FASN. Taking advantage of our extensive quantitative immunofluorescence data specific for EGR­1, PDGF­A, MIC­1, and FASN generated in disease­free, tumor­adjacent, and cancerous human prostate tissues, we chose comprehensive correlation as our major approach to test this hypothesis. Despite the static nature and sample heterogeneity of association studies, we show here that sophisticated data generation, such as by spectral image acquisition, linear unmixing, and digital quantitative imaging, can provide meaningful indications of molecular regulations in a physiologically relevant in situ environment. Our data suggest that EGR­1 acts as a key regulator of prostate field effect through induction of pro­proliferative (PDGF­A and FASN), and suppression of pro­apoptotic (MIC­1) factors. These findings were corroborated by computational promoter analyses and cell transfection experiments in non­cancerous prostate epithelial cells with ectopically induced and suppressed EGR­1 expression. Among several clinical applications, a detailed knowledge of pathways of field effect may lead to the development of targeted intervention strategies preventing progression from pre-malignancy to cancer.

2.
PLoS One ; 10(3): e0119314, 2015.
Article in English | MEDLINE | ID: mdl-25767870

ABSTRACT

Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p<0.0001 to p = 0.08 and p<0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p<0.0001 to p<0.05 and p<0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p<0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p<0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter- and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.


Subject(s)
Growth Differentiation Factor 15/metabolism , Platelet-Derived Growth Factor/metabolism , Prostate/metabolism , Prostatic Neoplasms/metabolism , Adult , Aged , Gene Expression/physiology , Humans , Male , Middle Aged , Prostate/pathology , Prostatic Neoplasms/pathology
3.
J Org Chem ; 78(22): 11221-8, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24127771

ABSTRACT

Syringaldehyde- and vanillin-based antioxidant dendrimers were synthesized via microwave-assisted alkyne-azide 1,3-dipolar cycloaddition using copper granules as a catalyst. The use of Cu(I) as a catalyst resulted in copper contaminated dendrimers. To produce copper-free antioxidant dendrimers for biological applications, Cu(I) was substituted with copper granules. Copper granules were ineffective at both room temperature and under reflux conditions (<5% yield). However, they were an excellent catalyst when dendrimer synthesis was performed under microwave irradiation, giving yields up to 94% within 8 h. ICP-mass analysis of the antioxidant dendrimers obtained with this method showed virtually no copper contamination (9 ppm), which was the same as the background level. The synthesized antioxidants, free from copper contamination, demonstrated potent radical scavenging with IC50 values of less than 3 µM in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. In comparison, dendrimers synthesized from Cu(I)-catalyzed click chemistry showed a high level of copper contamination (4800 ppm) and no detectable antioxidant activity.


Subject(s)
Copper/chemistry , Dendrimers/chemical synthesis , Microwaves , Organometallic Compounds/chemistry , Polyphenols/chemical synthesis , Alkynes/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Azides/chemistry , Catalysis , Click Chemistry , Cyclization , Dendrimers/chemistry , Molecular Structure , Polyphenols/chemistry
4.
J Biol Chem ; 285(46): 35567-77, 2010 Nov 12.
Article in English | MEDLINE | ID: mdl-20826791

ABSTRACT

Polyglutamine expansion within the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA) and is associated with misfolded and aggregated species of the mutant AR. We showed previously that nuclear localization of the mutant AR was necessary but not sufficient for SBMA. Here we show that an interdomain interaction of the AR that is central to its function within the nucleus is required for AR aggregation and toxicity. Ligands that prevent the interaction between the amino-terminal FXXLF motif and carboxyl-terminal AF-2 domain (N/C interaction) prevented toxicity and AR aggregation in an SBMA cell model and rescued primary SBMA motor neurons from 5α-dihydrotestosterone-induced toxicity. Moreover, genetic mutation of the FXXLF motif prevented AR aggregation and 5α-dihydrotestosterone toxicity. Finally, selective androgen receptor modulators, which prevent the N/C interaction, ameliorated AR aggregation and toxicity while maintaining AR function, highlighting a novel therapeutic strategy to prevent the SBMA phenotype while retaining AR transcriptional function.


Subject(s)
Mutation , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Trinucleotide Repeat Expansion/genetics , Amino Acid Motifs/genetics , Amino Acid Sequence , Androgen Antagonists/pharmacology , Androgens/pharmacology , Anilides/pharmacology , Animals , Binding Sites/genetics , Blotting, Western , Bulbo-Spinal Atrophy, X-Linked/genetics , Bulbo-Spinal Atrophy, X-Linked/metabolism , Bulbo-Spinal Atrophy, X-Linked/pathology , Cells, Cultured , Dihydrotestosterone/pharmacology , HEK293 Cells , Humans , Mice , Mice, Transgenic , Microscopy, Fluorescence , Motor Neurons/cytology , Motor Neurons/metabolism , Nitriles/pharmacology , PC12 Cells , Protein Binding/drug effects , Rats , Receptors, Androgen/chemistry , Testosterone/pharmacology , Tosyl Compounds/pharmacology , Two-Hybrid System Techniques
5.
J Nutr ; 134(9): 2359-64, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15333729

ABSTRACT

The microflorae in the intestine of breast-fed infants are distinct from those that typically populate the intestine of formula-fed infants. Although the acquisition of passive immunity through breast-feeding may play a critical role in influencing the pattern of bacterial colonization of the gut, the precise mechanisms underlying the differences in the commensal microflorae of breast and formula-fed children have not been established. We hypothesized that the assemblage of commensal microflorae in suckling and weaned mice may be influenced by the maternal adaptive immune system. To test this hypothesis, we analyzed the intestinal microflorae of mice reared in the presence (wild-type) or absence of an intact maternal immune system (T- and B-cell deficient). Several types of bacteria (Lactobacillus, Enterococcus, Clostridium perfringens, Bifidobacterium, and Bacteroides) were isolated and enumerated from both the small and large intestine of 10-, 18-, 25- and 40- to 60-d old mice using selective media. The densities of bacteria were significantly lower in the small intestine of weaned mice that were reared by wild-type (WT) compared with immunodeficient (ID) dams. However, the microflorae were generally more abundant in the large intestine of suckling pups reared by WT compared with ID dams. Our results indicate that intestinal microflorae change throughout the suckling phase of development and that the maternal adaptive immune system influences the pattern and abundance of bacteria within the gut in an age- and site-specific manner.


Subject(s)
Animals, Suckling/microbiology , Bacteria/isolation & purification , Immunity , Intestine, Large/microbiology , Intestine, Small/microbiology , Mothers , Aging/immunology , Animals , Animals, Suckling/growth & development , Colony Count, Microbial , Female , Immunologic Deficiency Syndromes/physiopathology , Intestine, Large/growth & development , Intestine, Small/growth & development , Lactation , Mice , Weaning
6.
J Neurosci ; 24(20): 4778-86, 2004 May 19.
Article in English | MEDLINE | ID: mdl-15152038

ABSTRACT

Transgenic models of neurodegenerative disease have proved uniquely powerful for delineating pathways of neuronal dysfunction and cell death. We have developed a transgenic model of the polyglutamine disease spinal and bulbar muscular atrophy (SBMA), an adult-onset, slowly progressive motor neuron disease caused by polyglutamine expansion in the androgen receptor (AR). Mice bearing a human AR with 112 glutamines reproduce many aspects of SBMA, including slowly progressive, gender-specific motor deficits, and neuronal intranuclear inclusions. Despite substantial motor deficits in male AR112Q mice, no motor neuron loss was observed, indicating that neuronal dysfunction, rather than neuronal death, is central to disease. Moreover, reduced levels of unphosphorylated neurofilament heavy chain (NF-H) were observed in motor neurons, suggesting a role for NF-H in SBMA neuronal dysfunction. The elimination of androgens by surgical castration of severely affected, aged 112Q male mice partially restored motor function as well as NF-H levels. These data suggest that hormone-based therapies designed to treat SBMA patients, even with advanced disease, are likely to be effective.


Subject(s)
Castration , Muscular Disorders, Atrophic/physiopathology , Muscular Disorders, Atrophic/surgery , Neurofilament Proteins/metabolism , Recovery of Function , Animals , Brain/pathology , Disease Models, Animal , Disease Progression , Humans , Lameness, Animal/genetics , Male , Mice , Mice, Transgenic , Motor Activity/genetics , Motor Neurons/metabolism , Motor Neurons/pathology , Muscle Weakness/genetics , Muscular Disorders, Atrophic/genetics , Peptides/genetics , Phosphorylation , Receptors, Androgen/genetics , Sex Factors , Spinal Cord/pathology , Treatment Outcome
7.
Am J Physiol Gastrointest Liver Physiol ; 285(4): G714-25, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12969828

ABSTRACT

Numerous genes expressed by intestinal epithelial cells are developmentally regulated, and the influence that adaptive (AI) and passive (PI) immunity have in controlling their expression has not been evaluated. In this study, we tested the hypothesis that both PI and AI influenced enterocyte gene expression by developing a breeding scheme that used T and B cell-deficient recombination-activating gene (RAG) mice. RNA was isolated from the liver and proximal/distal small intestine at various ages, and the steady-state levels of six different transcripts were evaluated by RNase protection assay. In wild-type (WT) pups, all transcripts [Fc receptor of the neonate (FcRn), polymeric IgA receptor (pIgR), GLUT5, lactase-phlorizin hydrolase (lactase), apical sodium-dependent bile acid transporter (ASBT), and Na+/glucose cotransporter (SGLT1)] studied were developmentally regulated at the time of weaning, and all transcripts except ASBT had the highest levels of expression in the proximal small intestine. In WT suckling pups reared in the absence of PI, pIgR mRNA levels were increased 100% during the early phase of development. In mice lacking AI, the expression of pIgR and lactase were significantly attenuated, whereas FcRn and GLUT5 levels were higher compared with WT mice. Finally, in the absence of both passive and active immunity, expression levels of pIgR and lactase were significantly lower than similarly aged WT mice. In summary, we report that the adaptive and passive immune status of mice influences steady-state mRNA levels of several important, developmentally regulated enterocyte genes during the suckling and weaning periods of life.


Subject(s)
Enterocytes/immunology , Enterocytes/metabolism , Gene Expression Regulation, Developmental/immunology , Immunity , Organic Anion Transporters, Sodium-Dependent , Symporters , Animals , Animals, Suckling , B-Lymphocytes/immunology , Carrier Proteins/genetics , Enterocytes/chemistry , Genes, RAG-1/genetics , Genes, RAG-1/immunology , Glucose Transporter Type 5 , Immunity, Active/physiology , Immunity, Maternally-Acquired/physiology , Intestine, Small/chemistry , Lactase-Phlorizin Hydrolase/genetics , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Monosaccharide Transport Proteins/genetics , RNA, Messenger/analysis , Receptors, Fc/genetics , Sodium-Glucose Transporter 1 , T-Lymphocytes/immunology , Weaning
SELECTION OF CITATIONS
SEARCH DETAIL
...